HAEMONETICS CORP — Director's Dealing 2010

Nov 9, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-11-08

Reporting Person: LINDOP CHRISTOPHER J (CFO &amp Vice President of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-08	Common Stock	D	140.0	$57.5094	Disposed	11097.0	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.